SkinBioTherapeutics is a biotech firm that specializes in enhancing skin wellness. The company's unique SkinBiotix® technology is built on the research findings of Professor Catherine O'Neill and Professor Andrew McBain.
| Industry: | Health Care |
| Sector: | Health Care |
| LEI: | 213800YMQOCB23FX6I06 |
| Region: | Europe |
| Admission date: | 5 Apr 2017 |
| Website: | www.skinbiotherapeutics.com |
| Twitter: | @SkinBioT |
| 26 Nov 2025 | Holding(s) in Company |
| 19 Nov 2025 | Holding(s) in Company |
| 4 Nov 2025 | Holding(s) in Company |
| 26 Nov 2025 | Holding(s) in Company |
| 19 Nov 2025 | Holding(s) in Company |
| 4 Nov 2025 | Holding(s) in Company |
| 14 Oct 2025 | Directorate Change |
| 13 Oct 2025 | Holding(s) in Company |
| 13 Oct 2025 | Holding(s) in Company |
| 6 Oct 2025 | Superdrug first phase of store locations |
| 1 Oct 2025 | Holding(s) in Company |
| 14 Aug 2025 | FY Trading Update |
| 30 Jun 2025 | Croda Commercial Launch Progressing as Expected |
| Current Price: | 16.50p |
| Change: | 0.38p (2.33%) |
| Open: | 16.13p |
| High: | 16.50p |
| Low: | 15.79p |
| Close: | 16.13p |
| Volume: | 360,065 |
| ISIN: | GB00BF33H870 |
| Exchange: | AIMX |
| Market: | Aim |
| Market Segment: | ASQ1 |
| Market Sector: | AMQ1 |
| Shares in issue: | 231,725,383 |
| Total Voting Rights: | 231,725,383 |
Calendar data will load here
Reports data will load here